STEMPOINT CAPITAL LP Hedge Fund

Location: New York, NY

CIK: 0001952142 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $581M (100.0% shares, 0.0% debt)

Holdings (84)

New Positions (34)

KNSA KINIKSA PHARMACEUTICALS INTL 2.3%
Value $13.38M Shares 209,234 Est. Cost Unrealized
TRAX FIRST TRACKS BIOTHERAPEUTICS 2.2%
Value $12.53M Shares 622,723 Est. Cost Unrealized
ORKA ORUKA THERAPEUTICS INC 1.9%
Value $11.08M Shares 116,461 Est. Cost Unrealized
CLYM CLIMB BIO INC 1.7%
Value $9.685M Shares 742,745 Est. Cost Unrealized
IFRX INFLARX NV 1.2%
Value $7.231M Shares 3,228,255 Est. Cost Unrealized
OVID OVID THERAPEUTICS INC 1.1%
Value $6.502M Shares 2,417,283 Est. Cost Unrealized
EQ EQUILLIUM INC 1.1%
Value $6.453M Shares 2,016,607 Est. Cost Unrealized
GLTO DAMORA THERAPEUTICS INC 1.0%
Value $5.623M Shares 216,194 Est. Cost Unrealized
IVA INVENTIVA SA 0.9%
Value $5.391M Shares 1,426,320 Est. Cost Unrealized
IPSC CENTURY THERAPEUTICS INC 0.9%
Value $5.258M Shares 2,146,182 Est. Cost Unrealized
AURA AURA BIOSCIENCES INC 0.9%
Value $5.071M Shares 714,280 Est. Cost Unrealized
CMPS COMPASS PATHWAYS PLC 0.7%
Value $4.029M Shares 284,769 Est. Cost Unrealized
AVLN AVALYN PHARMACEUTICALS INC 0.7%
Value $3.885M Shares 118,000 Est. Cost Unrealized
AXSM AXSOME THERAPEUTICS INC. 0.6%
Value $3.763M Shares 15,375 Est. Cost Unrealized
GLUE MONTE ROSA THERAPEUTICS INC 0.6%
Value $3.716M Shares 153,544 Est. Cost Unrealized
PSNL PERSONALIS INC 0.6%
Value $3.32M Shares 247,783 Est. Cost Unrealized
CBIO CRESCENT BIOPHARMA INC. 0.6%
Value $3.283M Shares 182,382 Est. Cost Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 0.6%
Value $3.195M Shares 39,198 Est. Cost Unrealized
KOD KODIAK SCIENCES INC 0.5%
Value $2.956M Shares 75,872 Est. Cost Unrealized
MNPR MONOPAR THERAPEUTICS INC 0.5%
Value $2.789M Shares 30,125 Est. Cost Unrealized
RAPP RAPPORT THERAPEUTICS INC 0.5%
Value $2.774M Shares 66,582 Est. Cost Unrealized
CUE CUE BIOPHARMA INC 0.4%
Value $2.114M Shares 66,995 Est. Cost Unrealized
CALC CALCIMEDICA INC 0.2%
Value $1.196M Shares 1,244,864 Est. Cost Unrealized
CLRB CELLECTAR BIOSCIENCES INC 0.2%
Value $987K Shares 354,938 Est. Cost Unrealized
PSNL PERSONALIS INC 0.1%
Value $811K Shares 470,000 Est. Cost Unrealized
PRQR PROQR THRAPEUTICS N V 0.1%
Value $802K Shares 431,054 Est. Cost Unrealized
BHVN BIOHAVEN LTD 0.1%
Value $525K Shares 500,000 Est. Cost Unrealized
XBI SPDR SERIES TRUST 0.1%
Value $400K Shares 250,000 Est. Cost Unrealized
AZN ASTRAZENECA PLC 0.0%
Value $180K Shares 25,000 Est. Cost Unrealized
TNGX TANGO THERAPEUTICS INC 0.0%
Value $175K Shares 100,000 Est. Cost Unrealized
ERAS ERASCA INC 0.0%
Value $90,000 Shares 200,000 Est. Cost Unrealized
ARKG ARK ETF TR 0.0%
Value $75,000 Shares 100,000 Est. Cost Unrealized
ROIV ROIVANT SCIENCES LTD 0.0%
Value $40,000 Shares 100,000 Est. Cost Unrealized
AMGN AMGEN INC 0.0%
Value $15,000 Shares 15,000 Est. Cost Unrealized

Increased Positions (19)

TNGX TANGO THERAPEUTICS INC 6.6%
Value $38.23M (+809.6%) Shares 1,223,019 (+508.7%) Est. Cost Unrealized
ERAS ERASCA INC 4.9%
Value $28.69M (+639.2%) Shares 1,565,913 (+552.8%) Est. Cost Unrealized
TYRA TYRA BIOSCIENCES INC 3.5%
Value $20.21M (+173.2%) Shares 632,754 (+227.6%) Est. Cost Unrealized
DNTH DIANTHUS THERAPEUTICS INC 3.4%
Value $19.58M (+172.9%) Shares 200,851 (+134.9%) Est. Cost Unrealized
ALKS ALKERMES PLC 2.2%
Value $12.99M (+356.6%) Shares 248,015 (+208.1%) Est. Cost Unrealized
SRZN SURROZEN INC 2.4%
Value $13.79M (+141.5%) Shares 602,798 (+207.6%) Est. Cost Unrealized
RLMD RELMADA THERAPEUTICS INC 1.7%
Value $10.1M (+143.0%) Shares 1,460,093 (+144.4%) Est. Cost Unrealized
BIOA BIOAGE LABS INC 2.0%
Value $11.38M (+92.1%) Shares 464,171 (+37.1%) Est. Cost Unrealized
ZURA ZURA BIO LTD 1.4%
Value $8.072M (+80.1%) Shares 1,368,215 (+81.6%) Est. Cost Unrealized
CELC CELCUITY INC 1.8%
Value $10.27M (+49.9%) Shares 98,203 (+63.5%) Est. Cost Unrealized
QURE UNIQURE NV 0.7%
Value $4.059M (+218.0%) Shares 88,115 (+12.9%) Est. Cost Unrealized
SLDB SOLID BIOSCIENCES INC 0.6%
Value $3.584M (+154.8%) Shares 358,780 (+83.6%) Est. Cost Unrealized
SPRB SPRUCE BIOSCIENCES INC 0.4%
Value $2.235M (+437.7%) Shares 41,388 (+550.8%) Est. Cost Unrealized
MLYS MINERALYS THERAPEUTICS INC 2.8%
Value $16.26M (+12.5%) Shares 602,686 (+13.0%) Est. Cost Unrealized
MPLT MAPLIGHT THERAPEUTICS INC 0.7%
Value $3.832M (+88.5%) Shares 106,906 (+6.9%) Est. Cost Unrealized
WHWK WHITEHAWK THERAPEUTICS INC 0.8%
Value $4.676M (+44.3%) Shares 1,021,037 (+8.7%) Est. Cost Unrealized
CCCC C4 THERAPEUTICS INC 0.4%
Value $2.445M (+105.2%) Shares 523,648 (+15.5%) Est. Cost Unrealized
SION SIONNA THERAPEUTICS INC 0.5%
Value $2.614M (+78.5%) Shares 59,426 (+62.6%) Est. Cost Unrealized
XBI SPDR SERIES TRUST 0.0%
Value $178K (+8.4%) Shares 400,000 (+166.7%) Est. Cost Unrealized

Exited Positions (32)

SNDX SYNDAX PHARMACEUTICALS INC 4.9%
Value $28.4M Shares 1,215,743 Est. Cost Unrealized
MBX MBX BIOSCIENCES INC 2.6%
Value $14.91M Shares 499,469 Est. Cost Unrealized
DYN DYNE THERAPEUTICS INC 1.6%
Value $9.175M Shares 506,075 Est. Cost Unrealized
EWTX EDGEWISE THERAPEUTICS INC 1.6%
Value $9.162M Shares 290,864 Est. Cost Unrealized
DNLI DENALI THERAPEUTICS INC 1.4%
Value $8.19M Shares 426,561 Est. Cost Unrealized
NRIX NURIX THERAPEUTICS INC 0.8%
Value $4.886M Shares 315,226 Est. Cost Unrealized
EVMN EVOMMUNE INC 0.8%
Value $4.385M Shares 193,777 Est. Cost Unrealized
SNSE SENSEI BIOTHERAPEUTICS INC 0.7%
Value $4.188M Shares 132,873 Est. Cost Unrealized
JNJ JOHNSON & JOHNSON 0.6%
Value $3.768M Shares 15,415 Est. Cost Unrealized
XFOR X4 PHARMACEUTICALS INC 0.6%
Value $3.514M Shares 850,742 Est. Cost Unrealized
PCVX VAXCYTE INC 0.6%
Value $3.432M Shares 59,061 Est. Cost Unrealized
IVVD INVIVYD INC 0.4%
Value $2.437M Shares 1,874,546 Est. Cost Unrealized
JBIO JADE BIOSCIENCES INC 0.4%
Value $2.164M Shares 154,034 Est. Cost Unrealized
TWST TWIST BIOSCIENCE CORP 0.4%
Value $2.049M Shares 43,110 Est. Cost Unrealized
AVTX AVALO THERAPEUTICS INC 0.3%
Value $2.012M Shares 134,742 Est. Cost Unrealized
IONS IONIS PHARMACEUTICALS INC 0.3%
Value $1.981M Shares 26,385 Est. Cost Unrealized
IMCR IMMUNOCORE HLDGS PLC 0.3%
Value $1.916M Shares 63,543 Est. Cost Unrealized
FBRX FORTE BIOSCIENCES INC 0.3%
Value $1.503M Shares 58,020 Est. Cost Unrealized
LPCN LIPOCINE INC NEW 0.2%
Value $1.282M Shares 160,420 Est. Cost Unrealized
EW EDWARDS LIFESCIENCES CORP 0.2%
Value $1.168M Shares 14,588 Est. Cost Unrealized
CAPR CAPRICOR THERAPEUTICS INC 0.2%
Value $1.143M Shares 37,592 Est. Cost Unrealized
SRRK SCHOLAR ROCK HLDG CORP 0.1%
Value $588K Shares 100,000 Est. Cost Unrealized
STRO SUTRO BIOPHARMA INC 0.1%
Value $580K Shares 23,295 Est. Cost Unrealized
TYRA TYRA BIOSCIENCES INC 0.0%
Value $290K Shares 100,000 Est. Cost Unrealized
IMVT IMMUNOVANT INC 0.0%
Value $255K Shares 100,000 Est. Cost Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.0%
Value $90,000 Shares 150,000 Est. Cost Unrealized
SPY STATE STR SPDR S&P 500 ETF T 0.0%
Value $85,500 Shares 50,000 Est. Cost Unrealized
QQQ INVESCO QQQ TR 0.0%
Value $74,200 Shares 40,000 Est. Cost Unrealized
BSX BOSTON SCIENTIFIC CORP 0.0%
Value $12,500 Shares 250,000 Est. Cost Unrealized
TERN TERNS PHARMACEUTICALS INC 0.0%
Value $7,500 Shares 100,000 Est. Cost Unrealized
OLMA OLEMA PHARMACEUTICALS INC 0.0%
Value $3,750 Shares 25,000 Est. Cost Unrealized
EW EDWARDS LIFESCIENCES CORP 0.0%
Value $1,000 Shares 10,000 Est. Cost Unrealized

Decreased Positions (29)

SRRK SCHOLAR ROCK HLDG CORP 2.3%
Value $13.15M (-74.2%) Shares 239,146 (-76.9%) Est. Cost Unrealized
IMVT IMMUNOVANT INC 1.8%
Value $10.65M (-42.5%) Shares 276,527 (-63.0%) Est. Cost Unrealized
GPCR STRUCTURE THERAPEUTICS INC 0.4%
Value $2.049M (-78.8%) Shares 38,178 (-80.9%) Est. Cost Unrealized
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.4%
Value $2.594M (-73.4%) Shares 98,945 (-76.1%) Est. Cost Unrealized
PRAX PRAXIS PRECISION MEDICINES I 2.1%
Value $12.47M (-31.2%) Shares 37,243 (-33.8%) Est. Cost Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 0.3%
Value $1.998M (-73.9%) Shares 16,303 (-77.5%) Est. Cost Unrealized
EYPT EYEPOINT INC 0.8%
Value $4.84M (-53.7%) Shares 338,471 (-58.3%) Est. Cost Unrealized
XENE XENON PHARMACEUTICALS INC 0.8%
Value $4.592M (-43.9%) Shares 76,075 (-46.0%) Est. Cost Unrealized
ELVN ENLIVEN THERAPEUTICS INC 3.0%
Value $17.61M (+23.6%) Shares 346,914 (-4.5%) Est. Cost Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 0.5%
Value $2.629M (-54.5%) Shares 77,589 (-57.1%) Est. Cost Unrealized
ABVX ABIVAX SA 6.5%
Value $37.8M (+8.2%) Shares 283,657 (-9.6%) Est. Cost Unrealized
CGON CG ONCOLOGY INC 2.0%
Value $11.32M (-18.6%) Shares 159,349 (-22.5%) Est. Cost Unrealized
RVMD REVOLUTION MEDICINES INC 5.2%
Value $29.95M (+9.4%) Shares 159,943 (-43.2%) Est. Cost Unrealized
AMLX AMYLYX PHARMACEUTICALS INC 1.2%
Value $6.902M (-25.9%) Shares 384,304 (-42.6%) Est. Cost Unrealized
BHVN BIOHAVEN LTD 2.7%
Value $15.84M (+17.4%) Shares 1,064,200 (-33.3%) Est. Cost Unrealized
CYTK CYTOKINETICS INC 1.1%
Value $6.441M (-24.6%) Shares 75,603 (-41.7%) Est. Cost Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.6%
Value $3.622M (-32.9%) Shares 143,167 (-41.0%) Est. Cost Unrealized
ROIV ROIVANT SCIENCES LTD 2.1%
Value $12.33M (+15.4%) Shares 348,408 (-9.7%) Est. Cost Unrealized
TENX TENAX THERAPEUTICS INC 0.2%
Value $1.401M (-53.6%) Shares 96,273 (-49.0%) Est. Cost Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 1.1%
Value $6.639M (-17.7%) Shares 178,412 (-29.8%) Est. Cost Unrealized
HLXC HELIX ACQUISITION CORP III 0.3%
Value $1.827M (-41.1%) Shares 171,671 (-43.7%) Est. Cost Unrealized
ALMS ALUMIS INC 0.7%
Value $3.82M (-24.5%) Shares 135,736 (-40.9%) Est. Cost Unrealized
SYRE SPYRE THERAPEUTICS INC 1.6%
Value $9.493M (+12.3%) Shares 106,926 (-36.2%) Est. Cost Unrealized
ASMB ASSEMBLY BIOSCIENCES INC 0.8%
Value $4.682M (-9.0%) Shares 170,378 (-8.1%) Est. Cost Unrealized
RVMD REVOLUTION MEDICINES INC 0.0%
Value $128K (-75.7%) Shares 30,000 (-70.0%) Est. Cost Unrealized
PHVS PHARVARIS N V 0.5%
Value $2.798M (+14.3%) Shares 80,907 (-6.6%) Est. Cost Unrealized
DFTX DEFINIUM THERAPEUTICS INC 1.1%
Value $6.45M (+4.9%) Shares 137,124 (-57.9%) Est. Cost Unrealized
LBRX LB PHARMACEUTICALS INC 0.2%
Value $1.032M (-16.3%) Shares 31,785 (-36.4%) Est. Cost Unrealized
SABS SAB BIOTHERAPEUTICS INC 0.2%
Value $1.336M (-7.0%) Shares 342,631 (-8.6%) Est. Cost Unrealized

Unchanged Positions (2)